{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:16:13Z","timestamp":1761894973684,"version":"3.37.0"},"reference-count":43,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T00:00:00Z","timestamp":1254096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>In mouse tail arteries, selective \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptor antagonism with rauwolscine caused powerful dilation during constriction to the \u03b1<jats:sub>1<\/jats:sub>\u2010adrenoceptor agonist phenylephrine. This study therefore assessed phenylephrine's selectivity at vascular \u03b1\u2010adrenoceptors and the mechanism(s) underlying dilation to rauwolscine.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Mouse isolated tail arteries were assessed using a pressure myograph.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>The \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonist UK14,304 caused low\u2010maximum constriction that was inhibited by rauwolscine (3 \u00d7 10<jats:sup>\u22128<\/jats:sup>\u2003M) but not by the selective \u03b1<jats:sub>1<\/jats:sub>\u2010adrenoceptor antagonist prazosin (10<jats:sup>\u22127<\/jats:sup>\u2003M). Concentration\u2013effect curves to phenylephrine, cirazoline or noradrenaline were unaffected by rauwolscine but were inhibited by prazosin, which was more effective at high compared with low levels of constriction. In the presence of prazosin, rauwolscine inhibited the curves and was more effective at low compared with high levels of constriction. Although rauwolscine alone did not affect concentration\u2013effect curves to phenylephrine, noradrenaline or cirazoline, it caused marked transient dilation when administered during constriction to these agonists. Dilation was mimicked by another \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptor antagonist (RX821002, 3 \u00d7 10<jats:sup>\u22128<\/jats:sup>\u2003M), was dependent on agonist selectivity, and did not occur during adrenoceptor\u2010independent constriction (U46619). During constriction to UK14,304 plus U46619, rauwolscine or rapid removal of UK14,304 caused transient dilation that virtually abolished the combined constriction. Endothelial denudation reduced these dilator responses.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Inhibition of \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptors caused transient dilation that was substantially greater than the contribution of \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptors to the constriction. This reflects a slowly reversing \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptor\u2010mediated endothelium\u2010dependent dilation and provides a rapid, sensitive test of \u03b1<jats:sub>2<\/jats:sub>\u2010adrenoceptor activity. This approach also clearly emphasizes the poor selectivity of phenylephrine at vascular \u03b1\u2010adrenoceptors.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00403.x","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T14:18:43Z","timestamp":1254147523000},"page":"1344-1355","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acute dilation to \u03b1<sub>2<\/sub>\u2010adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial \u03b1<sub>2<\/sub>\u2010adrenoceptors"],"prefix":"10.1111","volume":"158","author":[{"given":"PA","family":"Crassous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Flavahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NA","family":"Flavahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707746"},{"key":"e_1_2_7_3_1","first-page":"2355","article-title":"The alpha adrenoceptors on endothelial cells","volume":"45","author":"Angus JA","year":"1986","journal-title":"Fed Proc"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200205000-00014"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2002.00091.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0022-3565(25)39421-8","article-title":"Binding and functional characterization of alpha\u20102 adrenergic receptor subtypes on pig vascular endothelium","volume":"267","author":"Bockman CS","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11449.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.278.4.H1075"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/305627a0"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90573-8"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90533-2"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02833.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.076653"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb07021.x"},{"key":"e_1_2_7_15_1","first-page":"P585","article-title":"Demonstration of simultaneous \u03b11\u2010adrenoceptor, \u03b12\u2010adrenoceptor, \u03b11\u2010adrenoceptor and \u03b12\u2010adrenoceptor mediated effects of phenylephrine in the cardiovascular system of the pithed rat","volume":"72","author":"Flavahan NA","year":"1981","journal-title":"Br J Pharmacol"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198401000-00030"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(86)90383-4"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3565(25)24859-5","article-title":"Alpha\u20101 and alpha\u20102 adrenoceptor: response coupling in canine saphenous and femoral veins","volume":"238","author":"Flavahan NA","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_19_1","first-page":"351","volume-title":"Vascular Smooth Muscle: Role of Receptor Subtypes and Receptor\u2010Reserve, in the Alpha1\u2010Adrenoceptor","author":"Flavahan NA","year":"1987"},{"key":"e_1_2_7_20_1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(25)21728-1","article-title":"Characterization of postjunctional alpha\u20101 and alpha\u20102 adrenoceptors activated by exogenous or nerve\u2010released norepinephrine in the canine saphenous vein","volume":"230","author":"Flavahan NA","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_21_1","first-page":"H950","article-title":"Cooling and alpha 1\u2010 and alpha 2\u2010adrenergic responses in cutaneous veins: role of receptor reserve","volume":"249","author":"Flavahan NA","year":"1985","journal-title":"Am J Physiol"},{"key":"e_1_2_7_22_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-5347(25)00268-X","article-title":"Human postjunctional alpha\u20101 and alpha\u20102 adrenoceptors: differential distribution in arteries of the limbs","volume":"241","author":"Flavahan NA","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1989.sp017475"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705975"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0031-6997(24)01495-9","article-title":"Vascular adrenoceptors: an update","volume":"53","author":"Guimaraes S","year":"2001","journal-title":"Pharmacol Rev"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00165554"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.88.3.325"},{"key":"e_1_2_7_28_1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0026-895X(24)13264-6","article-title":"Protean agonism at alpha2A\u2010adrenoceptors","volume":"53","author":"Jansson CC","year":"1998","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199907000-00023"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2008.154252"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.05.021"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2006.06.004"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198200041-00021"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00504373"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90670-3"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1139\/y04-086"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00317-4"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199107000-00002"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.5.779"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00123.2002"},{"key":"e_1_2_7_41_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-5347(25)00382-9","article-title":"Greater activation of smooth muscle alpha\u20102 adrenoceptors by epinephrine in distal than in proximal segments of rat tail artery","volume":"240","author":"Rajanayagam MA","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.085944"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.6.1379"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio705"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00403.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00403.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:26:43Z","timestamp":1739359603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00403.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,20]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00403.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00403.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"type":"print","value":"0007-1188"},{"type":"electronic","value":"1476-5381"}],"subject":[],"published":{"date-parts":[[2009,10,20]]},"assertion":[{"value":"2009-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}